MetaCap

Recursion Pharmaceuticals Statistics

NASDAQ: RXRXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.45-0.27 (-9.93%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Recursion Pharmaceuticals by the numbers

Recursion Pharmaceuticals has a market capitalization of $1.53 billion based on 622.76M shares outstanding. With trailing EPS of $-0.86, Recursion Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 34.1% below its 50-day average and 28.9% below its 200-day average.

Average daily trading volume is 24.47M shares, or about $59.9 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

RXRX valuation vs. peer median

RXRX compared with the median of 8 peer companies
MetricRXRXPeer medianDifference
Market cap$1.53B$1.52B+1%
Avg. volume24.47M594.01K+4019%

Peer median across 8 companies: VIR, ALVO, WWB, MESO, IMCR, MAZE, LYCA, REPL.

Valuation

Price / sales (latest FY)
20.45
EPS (TTM)
$-0.86

Price and trading

Previous close
2.72
Open
2.63
Day range
2.44 – 2.76
52-week range
2.44 – 5.24
52-week change
-41.25%
Beta
—
Volume
29.80M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.53B
Forward Pe
-3.03
Eps
-0.86
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
5.24
Week52 Low
2.44
Avg Volume
24.47M
Shares Outstanding
622.76M
Ma50
3.72
Ma200
3.44
Earnings Date
Nov 2, 2026
Pct From52w High
-53.24%
Pct From52w Low
0.41%

Related